全文获取类型
收费全文 | 43242篇 |
免费 | 2855篇 |
国内免费 | 123篇 |
专业分类
耳鼻咽喉 | 389篇 |
儿科学 | 1473篇 |
妇产科学 | 1196篇 |
基础医学 | 5848篇 |
口腔科学 | 747篇 |
临床医学 | 6568篇 |
内科学 | 8282篇 |
皮肤病学 | 656篇 |
神经病学 | 4337篇 |
特种医学 | 797篇 |
外科学 | 3889篇 |
综合类 | 523篇 |
一般理论 | 57篇 |
预防医学 | 5351篇 |
眼科学 | 592篇 |
药学 | 2376篇 |
中国医学 | 68篇 |
肿瘤学 | 3071篇 |
出版年
2023年 | 221篇 |
2022年 | 403篇 |
2021年 | 845篇 |
2020年 | 492篇 |
2019年 | 834篇 |
2018年 | 985篇 |
2017年 | 697篇 |
2016年 | 715篇 |
2015年 | 920篇 |
2014年 | 1310篇 |
2013年 | 1977篇 |
2012年 | 2943篇 |
2011年 | 3082篇 |
2010年 | 1706篇 |
2009年 | 1465篇 |
2008年 | 2842篇 |
2007年 | 2839篇 |
2006年 | 2843篇 |
2005年 | 2661篇 |
2004年 | 2561篇 |
2003年 | 2499篇 |
2002年 | 2313篇 |
2001年 | 477篇 |
2000年 | 418篇 |
1999年 | 532篇 |
1998年 | 490篇 |
1997年 | 447篇 |
1996年 | 391篇 |
1995年 | 343篇 |
1994年 | 329篇 |
1993年 | 314篇 |
1992年 | 380篇 |
1991年 | 352篇 |
1990年 | 328篇 |
1989年 | 291篇 |
1988年 | 262篇 |
1987年 | 274篇 |
1986年 | 221篇 |
1985年 | 266篇 |
1984年 | 262篇 |
1983年 | 238篇 |
1982年 | 257篇 |
1981年 | 230篇 |
1980年 | 197篇 |
1979年 | 212篇 |
1978年 | 161篇 |
1977年 | 133篇 |
1976年 | 120篇 |
1975年 | 113篇 |
1974年 | 140篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
191.
Dr. Vera J.S. Van de Velde Ph.D. Dr. Achiel P. Van Peer Ph.D. Dr. Joseph J.P. Heykants Ph.D. Mr. Robert J.H. Woestenborghs Chem. Eng. Dr. Patricia Van Rooy M.D. Mr. Karel L. De Beule Dip. Hosp. Pharm. Dr. Geert F.M.J. Cauwenbergh Ph.D. 《Pharmacotherapy》1996,16(3):424-428
Study Objective . To compare the pharmacokinetics of a single 100-mg oral dose of itraconazole administered as 10 ml of a 10-mg/ml itraconazole solution in hydroxypropyl-β-cyclodextrin under fasting versus postprandial conditions. Design . Open-label, two-way, randomized, crossover study. Setting . Janssen Research Foundation, Belgium. Patients . Twelve healthy volunteers. Interventions . Blood samples were obtained for pharmacokinetic analyses immediately before dosing and at regular intervals up to 96 hours after each dose. Blood and urine samples were obtained for hematologic, biochemical, and urinary safety analyses at baseline and at the end of the study. Measurements and Main Results . The mean peak plasma concentrations of both itraconazole and its active metabolite hydroxy-itraconazole were significantly higher under fasting conditions than under postprandial conditions. The mean times to peak concentration for both the parent compound and its metabolite were significantly shorter under fasting than under nonfasting conditions. The mean areas under the curve (AUC0–∞ and AUC0–24 hrs) were also significantly higher under fasting than under postprandial conditions. Conclusions . Our findings suggest that the higher bioavailability of this new formulation of itraconazole may be of benefit in seriously ill patients who are not able to ingest adequate quantities of food. The fact that the solution was also well tolerated and was not associated with clinically significant changes in any laboratory value further underscores the potential utility of this dosing form. 相似文献
192.
The greater potency of morphine-6-glucuronide (M6G) as well as the inactivity of morphine-3-glucuronide (M3G) with respect to the antinociceptive effects of the parent molecule, morphine (MOR), have been well established. It has been suggested that M3G is an antagonist of MOR's antinociceptive and respiratory depressive effects. The present study addressed the central nervous system (CNS) interaction of these opiate metabolites on their metabolic and hormonal effects. Whole body glucose kinetics were assessed on conscious, chronically catheterized, unrestrained rats. M3G (5 μg) or H2O (5 μl) was injected intracerebroventricularly (i.c.v.) 15 min prior to the bolus administration of H2O (5 μl), M6G (1 μg), or MOR (80 μg). i.c.v. M3G (5 μg) resulted in behavioral excitation, hyperglycemia (+50%), stimulation of glucose rate of appearance (Ra; +100%), glucose rate of disappeaance (Rd; +70%), and metabolic clearance rate (MCR; +33%) within 30 min after injection with no alterations in hormone concentrations. i.c.v. M6G and MOR produced progressive hyperglycemia with significantly high catecholamine and corticosterone levels. M3G pretreatment resulted in enhanced elevations in plasma glucose levels (+52% and +18%), plasma lactate (+138% and +108%), norepinephrine (+96% and +30%), and epinephrine (+62% and +67%) in response to both i.c.v. MOR and M6G administration. These findings suggest a non-opiate and non-hormonal mechanism for M3G-induced hyperglycemia. In contrast, the metabolic and hormonal responses to i.c.v. M6G and MOR are associated with elevations in catecholamine and corticosterone levels, which are remarkably enhanced by M3G pretreatment, most likely through accelerated catecholamine release. Our findings suggest a modulatory role for MOR glucuronidation, not only by rendering it inactive, as in the case of M3G, but by an interplay of the metabolic effects of the parent molecule and its metabolite 相似文献
193.
This article describes a study of the receptivity to and the feasibility of a patient education service for patients of private practice, primary care physicians. A stratified (by medical specialty), random sample of 400 private practice, primary care physicians in the State of Maryland was selected from the State medical society roster. In addition, a random sample of 800 health care consumers was selected from a listing of residents in a five county area of Maryland. Questionnaires were developed, pilot tested, revised, and eventually mailed to the physician and consumer samples. Completed questionnaires were obtained from 140 physicians and from 314 consumers. Results indicated that both physicians and consumers were receptive to patient education in the private practice medical setting. Based upon the findings, recommendations are offered regarding the manner in which patient education in a private practice medical setting should be organized. 相似文献
194.
195.
Certified nurse-midwives and family physicians share a philosophy of family-centered maternity care. Collaboration between the two disciplines, however, has not been common. Collaboration can enhance the primary care and maternity care options available to clients of such collaborative practices. Advantages and barriers to collaboration for both types of practitioners, as well as suggestions for successful collaboration, are discussed. 相似文献
196.
P L Greenberg 《Blood reviews》1991,5(1):42-50
Therapeutic options have been rapidly evolving for management of patients with the indolent myeloid clonal hemopathies termed myelodysplastic syndromes (MDS). Heterogeneity of MDS has been demonstrated on the basis of marrow morphology and biologic features and has been useful for prognostication into high and low risk groups for transformation to acute leukemia. Such stratification has been important for evaluating responses to various treatments. These therapeutic options include the differentiation-inducing vitamins retinoic acid and vitamin D, and cytokines such as alpha and gamma interferon, to which there has been a generally low response. The use of intensive or low dose chemotherapy has been associated with relatively low response rates, few durable responses and a high degree of hemopoietic toxicity. Allogeneic bone marrow transplantation (BMT) has shown durable responses for a subset of MDS patients, particularly those who are young and who are in the low risk subgroups. however, due to the elderly nature of the majority of MDS patients, and the toxicity associated with BMT, this option has limited utility for most of these patients. Major focus has been on the recent therapeutic use of recombinant human hemopoietic growth factors, particularly G-CSF, GM-CSF and IL3. These agents have been well-tolerated and generally produce a high incidence of sustained improvements in neutrophil counts and marrow morphology, although hemoglobin and platelet counts have generally not been altered. More extensive clinical trials evaluating the impact of these hemopoietic growth factors on the natural history of MDS are ongoing. 相似文献
197.
198.
Prevalence and Predictors of Adolescent Dating Violence 总被引:1,自引:0,他引:1
Patricia Y. Symons MSN RN CRNP Maureen W. Groër PhD RN Patricia Kepler-Youngblood MSW Victoria Slater MSN RN 《Journal of child and adolescent psychiatric nursing》1994,7(3):14-23
This study of 561 rural North Carolina adolescents examined relationships among race, parental educational level, family structure, parental discipline, family violence exposure, and dating violence experiences. The sample was predominantly female (77%), with 40% black and 58% white. The subjects ranged in age from 15 to 20 years; 80% of the adolescents were 16–18. Dating violence experiences were assessed by a researcher-constructed instrument measuring warning signs of potential violence and actual violent experiences. The results suggested that recognition of abusive relationships is difficult, with many adolescents denying such a relationship but actually reporting numerous abusive events. Sixty percent had experienced violent acts during dating relationships; 24% reported extreme violence (episodes of rape, use of weapons). More than 20% of the adolescents reported family violence and 2.2% reported family sexual abuse. The study suggests new avenues for research in adolescent date violence, and for interventions with high risk groups. 相似文献
199.
200.
The occupational health nurse can play an important role in supporting employees with CKD and ESRD by recognizing risk factors such as diabetes and hypertension associated with CKD. The occupational health nurse should encourage compliance with treatment regimens that retard or delay progression of kidney disease into the next stage, especially blood pressure and glucose control. When employees are in need of diagnostic testing, the occupational health nurse can describe the testing procedures such as laboratory values, ultrasounds, and biopsies, and explain the five stages of CKD. The occupational health nurse can assist employees in Stage 4 or 5 CKD in deciding on a treatment option modality that best suits their individual lifestyles, after they have seen a nephrologist and kidney patient educator. In addition, the occupational health nurse can guide employees with difficult lifestyle changes and provide support during the adjustment process. The occupational health nurse also can play a key role in facilitating and coordinating those changes with the renal social worker. Together they can explore available resources, such as the NKF, the American Association of Kidney Patients, and kidneydirections.com. See the Sidebar on pages 295 to 296 for other available resources. Kidney disease can be a devastating diagnosis. Support and education are key to a successful lifestyle transition. Employees who have CKD and work with an occupational health nurse who is informed about their disease and its stages of progression can benefit from educational processes that create informed choices to delay or retard the progression of their renal disease. 相似文献